Financial factors shaping treatment decisions in oncology: A systematic review.

J Cancer PolicyJul 21, 2026 (epub)
Clinical ResearchOncology (Medical)

Ebunoluwa J Olunuga, Joshua Woo, Anagh Kulkarni et al.

✦ AI-curated · Sources linked

In 30 seconds

This systematic review examined how financial factors influence treatment decisions in oncology, analyzing 60 studies. It found that financial incentives, particularly from industry, significantly affect prescribing behaviors, with physicians often caught between cost-conscious care and the desire to offer all beneficial therapies. The review highlights the need for systemic changes to support cost-effective oncology practices.

Key findings

  • Financial influences were identified across three domains: physician-industry, physician-patient, and physician-physician.
  • Industry payments and financial incentives were linked to increased prescribing of promoted drugs, especially with larger incentives.
  • Patient out-of-pocket costs frequently impacted treatment recommendations, though discussions about costs were less common.

Why it matters

Understanding the financial factors that shape treatment decisions is crucial for improving cost-conscious care in oncology. This knowledge can inform policy changes and support clinicians in navigating financial complexities in patient care.

Source

PubMed · PMID 42480903

Published in J Cancer Policy. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Oncology (Medical)

Clinical ResearchPreventive Medicine / Public Health

2025 National Guidelines on the Mediterranean Diet: Executive Summary of a Joint Report by Italian Scientific Societies and the National Institute of Health Task Force on Clinical Practice Guidelines.

This systematic review and practice guideline, developed by a multidisciplinary panel using NUTRIGRADE, assessed Mediterranean diet evidence across nine health domains and one economic domain.

Nutr RevNov 12, 2026Read summary
Clinical ResearchOrthopedic Surgery

Prevention of Venous Thromboembolism after Total Hip or Knee Replacement.

This multicenter randomized comparative-effectiveness noninferiority trial compared 30 days of aspirin, warfarin, or rivaroxaban for VTE prophylaxis after elective total hip or knee arthroplasty.

N Engl J MedNov 12, 2026Read summary
Clinical ResearchAnesthesiology

Effect of discontinuing antihypertensives on perioperative hypotension in older patients before non-cardiac surgery: multicentre, randomised, double blind, controlled trial.

This multicentre, randomised, double blind, placebo controlled trial assessed whether withholding ACE inhibitors or ARBs on the morning of surgery reduces perioperative hypotension in older adults undergoing non-cardiac…

BMJNov 11, 2026Read summary

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text
Create my personalized digestSee plans

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.